Sk Biopharmaceuticalsco Stock Return On Equity
326030 Stock | 87,500 1,100 1.24% |
Sk BiopharmaceuticalsCo fundamentals help investors to digest information that contributes to Sk Biopharmaceutica's financial success or failures. It also enables traders to predict the movement of 326030 Stock. The fundamental analysis module provides a way to measure Sk Biopharmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sk Biopharmaceutica stock.
326030 |
Sk BiopharmaceuticalsCo Company Return On Equity Analysis
Sk Biopharmaceutica's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sk Biopharmaceutica Return On Equity | -0.12 |
Most of Sk Biopharmaceutica's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sk BiopharmaceuticalsCo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Sk BiopharmaceuticalsCo has a Return On Equity of -0.1245. This is 99.48% lower than that of the Healthcare sector and 99.66% lower than that of the Biotechnology industry. The return on equity for all Republic of Korea stocks is 59.84% lower than that of the firm.
326030 Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sk Biopharmaceutica's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sk Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Sk Biopharmaceutica by comparing valuation metrics of similar companies.Sk Biopharmaceutica is currently under evaluation in return on equity category among related companies.
326030 Fundamentals
Return On Equity | -0.12 | |||
Return On Asset | 0.0475 | |||
Profit Margin | (0.12) % | |||
Operating Margin | 0.11 % | |||
Current Valuation | 5.87 T | |||
Shares Outstanding | 78.31 M | |||
Shares Owned By Insiders | 64.28 % | |||
Shares Owned By Institutions | 5.26 % | |||
Price To Book | 15.89 X | |||
Price To Sales | 13.94 X | |||
Revenue | 418.64 B | |||
Gross Profit | 396.31 B | |||
EBITDA | 83.87 B | |||
Net Income | 64.85 B | |||
Cash Flow From Operations | (92.87 B) | |||
Earnings Per Share | (117.74) X | |||
Target Price | 96154.0 | |||
Number Of Employees | 10 | |||
Beta | 1.11 | |||
Market Capitalization | 5.32 T | |||
Total Asset | 643.65 B | |||
Net Asset | 643.65 B |
About Sk Biopharmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sk BiopharmaceuticalsCo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sk Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sk BiopharmaceuticalsCo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sk Biopharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sk Biopharmaceutica's short interest history, or implied volatility extrapolated from Sk Biopharmaceutica options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sk BiopharmaceuticalsCo. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Sk BiopharmaceuticalsCo information on this page should be used as a complementary analysis to other Sk Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for 326030 Stock analysis
When running Sk Biopharmaceutica's price analysis, check to measure Sk Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sk Biopharmaceutica is operating at the current time. Most of Sk Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sk Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sk Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sk Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |